| Lonnie N Albin, MD | |
|
507 Harley Street, Scottsboro, AL 35768 | |
| (256) 259-5550 | |
| (256) 259-5552 |
| Full Name | Lonnie N Albin |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 507 Harley Street, Scottsboro, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629039045 | NPI | - | NPPES |
| 51517783 | Other | AL | BLUE CROSS BLUE SHIELD AL |
| 051517783 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20176 (Alabama) | Primary |
| Entity Name | Highlands Hospitalists Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154690246 PECOS PAC ID: 1759548886 Enrollment ID: O20120201000574 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
Researchers at the University of Alicante have developed high-precision software for diagnosing eye sensitivity. This is a new technology that allows to quantify the degree of opacity in the posterior capsule of the eye caused by the growth of cells in the intraocular lens.
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
An experimental research carried out in Sant Cugat del Vall-s and Rub-, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos.
› Verified 1 days ago
| Entity Name | Scottsboro Pediatrics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376966416 PECOS PAC ID: 1355573551 Enrollment ID: O20140422000043 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
Researchers at the University of Alicante have developed high-precision software for diagnosing eye sensitivity. This is a new technology that allows to quantify the degree of opacity in the posterior capsule of the eye caused by the growth of cells in the intraocular lens.
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
An experimental research carried out in Sant Cugat del Vall-s and Rub-, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos.
› Verified 1 days ago
| Entity Name | Scottsboro Urgent Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205267150 PECOS PAC ID: 6204051584 Enrollment ID: O20140630000240 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
Researchers at the University of Alicante have developed high-precision software for diagnosing eye sensitivity. This is a new technology that allows to quantify the degree of opacity in the posterior capsule of the eye caused by the growth of cells in the intraocular lens.
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
An experimental research carried out in Sant Cugat del Vall-s and Rub-, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos.
› Verified 1 days ago
| Entity Name | Highlands Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750041786 PECOS PAC ID: 0648666198 Enrollment ID: O20220408001223 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
Researchers at the University of Alicante have developed high-precision software for diagnosing eye sensitivity. This is a new technology that allows to quantify the degree of opacity in the posterior capsule of the eye caused by the growth of cells in the intraocular lens.
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
An experimental research carried out in Sant Cugat del Vall-s and Rub-, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lonnie N Albin, MD 507 Harley Street, Scottsboro, AL 35768 Ph: (256) 259-5550 | Lonnie N Albin, MD 507 Harley Street, Scottsboro, AL 35768 Ph: (256) 259-5550 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
Researchers at the University of Alicante have developed high-precision software for diagnosing eye sensitivity. This is a new technology that allows to quantify the degree of opacity in the posterior capsule of the eye caused by the growth of cells in the intraocular lens.
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
An experimental research carried out in Sant Cugat del Vall-s and Rub-, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos.
› Verified 1 days ago
Dr. Patrick Scott Berry, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1108 S Broad St Ste A, Scottsboro, AL 35768 Phone: 256-218-3230 Fax: 256-218-3249 | |
Dr. Bret Gordon Fremming, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 305 W Peachtree St, Scottsboro, AL 35768 Phone: 256-574-1100 Fax: 256-574-2700 | |
Chelsea Victoria Clark, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1108 S Broad St Ste A, Scottsboro, AL 35768 Phone: 256-218-3230 | |
Christopher Brian Clayton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 507 Harley St, Scottsboro, AL 35768 Phone: 256-259-0061 Fax: 256-259-0668 | |
Mandi Michelle Allen-bell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 405 Taylor Street, Suite A, Scottsboro, AL 35768 Phone: 256-574-1050 | |
Mark C Cooper, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Burlington St, Scottsboro, AL 35768 Phone: 256-259-4100 Fax: 256-259-4104 | |
Mr. Andrew Oliver White, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1302 South Broad Street, Scottsboro, AL 35768 Phone: 256-218-4080 Fax: 256-218-3147 |